These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 30068597

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Preexisting helminth infection induces inhibition of innate pulmonary anti-tuberculosis defense by engaging the IL-4 receptor pathway.
    Potian JA, Rafi W, Bhatt K, McBride A, Gause WC, Salgame P.
    J Exp Med; 2011 Aug 29; 208(9):1863-74. PubMed ID: 21825018
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. NK cell-derived IFN-gamma differentially regulates innate resistance and neutrophil response in T cell-deficient hosts infected with Mycobacterium tuberculosis.
    Feng CG, Kaviratne M, Rothfuchs AG, Cheever A, Hieny S, Young HA, Wynn TA, Sher A.
    J Immunol; 2006 Nov 15; 177(10):7086-93. PubMed ID: 17082625
    [Abstract] [Full Text] [Related]

  • 5. The lymphotoxin beta receptor is critically involved in controlling infections with the intracellular pathogens Mycobacterium tuberculosis and Listeria monocytogenes.
    Ehlers S, Hölscher C, Scheu S, Tertilt C, Hehlgans T, Suwinski J, Endres R, Pfeffer K.
    J Immunol; 2003 May 15; 170(10):5210-8. PubMed ID: 12734369
    [Abstract] [Full Text] [Related]

  • 6. Caspase-1 independent IL-1beta production is critical for host resistance to mycobacterium tuberculosis and does not require TLR signaling in vivo.
    Mayer-Barber KD, Barber DL, Shenderov K, White SD, Wilson MS, Cheever A, Kugler D, Hieny S, Caspar P, Núñez G, Schlueter D, Flavell RA, Sutterwala FS, Sher A.
    J Immunol; 2010 Apr 01; 184(7):3326-30. PubMed ID: 20200276
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. IL-1 receptor-mediated signal is an essential component of MyD88-dependent innate response to Mycobacterium tuberculosis infection.
    Fremond CM, Togbe D, Doz E, Rose S, Vasseur V, Maillet I, Jacobs M, Ryffel B, Quesniaux VF.
    J Immunol; 2007 Jul 15; 179(2):1178-89. PubMed ID: 17617611
    [Abstract] [Full Text] [Related]

  • 9. IRAK-M alters the polarity of macrophages to facilitate the survival of Mycobacterium tuberculosis.
    Shen P, Li Q, Ma J, Tian M, Hong F, Zhai X, Li J, Huang H, Shi C.
    BMC Microbiol; 2017 Aug 23; 17(1):185. PubMed ID: 28835201
    [Abstract] [Full Text] [Related]

  • 10. Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis.
    Kahnert A, Seiler P, Stein M, Bandermann S, Hahnke K, Mollenkopf H, Kaufmann SH.
    Eur J Immunol; 2006 Mar 23; 36(3):631-47. PubMed ID: 16479545
    [Abstract] [Full Text] [Related]

  • 11. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M, Shirakawa T.
    Kekkaku; 2005 Sep 23; 80(9):613-29. PubMed ID: 16245793
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-1 receptor type-1 in non-hematopoietic cells is the target for the pro-atherogenic effects of interleukin-1 in apoE-deficient mice.
    Shemesh S, Kamari Y, Shaish A, Olteanu S, Kandel-Kfir M, Almog T, Grosskopf I, Apte RN, Harats D.
    Atherosclerosis; 2012 Jun 23; 222(2):329-36. PubMed ID: 22236482
    [Abstract] [Full Text] [Related]

  • 13. Postoperative ileus involves interleukin-1 receptor signaling in enteric glia.
    Stoffels B, Hupa KJ, Snoek SA, van Bree S, Stein K, Schwandt T, Vilz TO, Lysson M, Veer CV, Kummer MP, Hornung V, Kalff JC, de Jonge WJ, Wehner S.
    Gastroenterology; 2014 Jan 23; 146(1):176-87.e1. PubMed ID: 24067878
    [Abstract] [Full Text] [Related]

  • 14. The Phagocyte Oxidase Controls Tolerance to Mycobacterium tuberculosis Infection.
    Olive AJ, Smith CM, Kiritsy MC, Sassetti CM.
    J Immunol; 2018 Sep 15; 201(6):1705-1716. PubMed ID: 30061198
    [Abstract] [Full Text] [Related]

  • 15. Is Receptor-Interacting Protein Kinase 3 a Viable Therapeutic Target for Mycobacterium tuberculosis Infection?
    Stutz MD, Ojaimi S, Ebert G, Pellegrini M.
    Front Immunol; 2018 Sep 15; 9():1178. PubMed ID: 29892302
    [Abstract] [Full Text] [Related]

  • 16. Hepatocyte-specific deletion of IL1-RI attenuates liver injury by blocking IL-1 driven autoinflammation.
    Gehrke N, Hövelmeyer N, Waisman A, Straub BK, Weinmann-Menke J, Wörns MA, Galle PR, Schattenberg JM.
    J Hepatol; 2018 May 15; 68(5):986-995. PubMed ID: 29366909
    [Abstract] [Full Text] [Related]

  • 17. The IL-27 receptor chain WSX-1 differentially regulates antibacterial immunity and survival during experimental tuberculosis.
    Hölscher C, Hölscher A, Rückerl D, Yoshimoto T, Yoshida H, Mak T, Saris C, Ehlers S.
    J Immunol; 2005 Mar 15; 174(6):3534-44. PubMed ID: 15749890
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA-125a Inhibits Autophagy Activation and Antimicrobial Responses during Mycobacterial Infection.
    Kim JK, Yuk JM, Kim SY, Kim TS, Jin HS, Yang CS, Jo EK.
    J Immunol; 2015 Jun 01; 194(11):5355-65. PubMed ID: 25917095
    [Abstract] [Full Text] [Related]

  • 19. Role of interleukin (IL)-1 type 1 receptor in mycobacterial infection.
    Sugawara I, Yamada H, Hua S, Mizuno S.
    Microbiol Immunol; 2001 Jun 01; 45(11):743-50. PubMed ID: 11791667
    [Abstract] [Full Text] [Related]

  • 20. Interleukin-1 mediates thermal injury-induced lung damage through C-Jun NH2-terminal kinase signaling.
    Chen LW, Chang WJ, Wang JS, Hsu CM.
    Crit Care Med; 2007 Apr 01; 35(4):1113-22. PubMed ID: 17334237
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.